Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease [Phase 1, Phase 2]
CRISPR Therapeutics reports safety data and preliminary efficacy signals for CTX112 in adults with relapsed/refractory warm autoimmune hemol…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). [Phase 3]
The document reports the completion of a long-term Phase 3 trial evaluating the safety and efficacy of efgartigimod in adults with primary i…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Research of Predictive Factors to Immune Thrombopenic Purpura [NA]
This clinical trial update notes that a study evaluating predictive factors for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) [Phase 3]
Phase 3 study evaluating rilzabrutinib in adults and adolescents with persistent or chronic immune thrombocytopenia has results posted and t…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: to Evaluate the Efficacy and Safety of Eltrombopag for Immune Thrombocytopenia With Chronic HBV Infection [Phase 2]
A Phase 2 study evaluating eltrombopag for immune thrombocytopenia in patients with chronic hepatitis B infection has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia [NA]
This clinical trial update reports on low-dose rituximab regimens in Chinese adults with immune thrombocytopenia and notes the study status …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)
Sanofi-sponsored clinical trial evaluating cognitive status, fatigue, and inflammation in adults with immune thrombocytopenia has completed.…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia [Phase 3]
A Phase 3 trial is evaluating the safety and efficacy of subcutaneous Efgartigimod in adults with primary immune thrombocytopenia. The study…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: ASPirin in Immune thRombocytopenia Patients With Cardiovascular disEase [Phase 2]
Phase 2 trial evaluating aspirin in patients with immune thrombocytopenia and cardiovascular disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: Lusutrombopag in the Treatment of Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 clinical trial evaluating lusutrombopag for immune thrombocytopenia has completed, assessing its potential to raise platelet counts …
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia [Phase 2]
A Phase 2 study evaluating VLX-1005 versus placebo for suspected heparin-induced thrombocytopenia was terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia [Phase 1]
A Phase I clinical trial of SHR-2173 injections in patients with primary immune thrombocytopenia is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) [Phase 2]
Phase 2 study of rilzabrutinib in adults with immune thrombocytopenia has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: Rilzabrutinib for the Adult Participants With Chronic ITP Who Have Completed Phase 3 Study in Japan [Phase 3]
This clinical trial update covers rilzabrutinib for adults with immune thrombocytopenia. It notes that a Phase 3 study conducted in Japan ha…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9 [Phase 3]
A Phase 3 trial assessing the combination of all-trans retinoic acid and eltrombopag for steroid-resistant or relapsed immune thrombocytopen…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: A Clinical Trial of Chidamide in the Management of Refractory ITP [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating chidamide for immune thrombocytopenia has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children [Phase 3]
Phase 3 trial evaluating eltrombopag versus standard frontline management for newly diagnosed immune thrombocytopenia in children has comple…
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia [Phase 3]
This clinical trial update indicates that a Phase 3 study evaluating hetrombopag for pediatric patients with chronic immune thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: Management of Children With Persistent ITP, A Novel Approach [NA]
This clinical trial update describes ongoing recruitment for a study evaluating a novel management approach for persistent immune thrombocyt…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP [Phase 2]
This is a Phase 2 clinical trial comparing iguratimod plus low-dose rituximab to low-dose rituximab alone in corticosteroid-resistant or rel…
-
CLINICAL_TRIALS trial_result · 2025-07-01Clinical Trial Update: Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP [Phase 4]
Phase 4 trial evaluating how often patients experience a prolonged response after stopping thrombopoietin-receptor agonists in persistent im…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia [Phase 2]
TAK-079 was studied in adults with persistent or chronic primary immune thrombocytopenia in a Phase 2 trial. The study is completed and resu…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: A Clinical Trial to Assess Safety and Efficacy of Daratumumab in the Treatment of Primary Immune Thrombocytopenia [Phase 2]
Phase 2 clinical trial assessing the safety and efficacy of daratumumab for primary immune thrombocytopenia is currently active but not recr…
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial [Phase 2]
Phase 2 multicenter interventional trial evaluating romiplostim combined with glucocorticoids as first-line therapy for newly diagnosed adul…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical study evaluating YTS109 cells in relapsed/refractory systemic lupus erythematosus, including lupus nephritis and immune t…